GT
Healthcare & Life Sciences
Guide Therapeutics
United States
Guide Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Guide Therapeutics
Based in the United States, Guide Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Guide Therapeutics develops lipid nanoparticles using DNA barcoding technology to identify and screen particles that can deliver nucleic-acid therapies specifically to targeted tissues and organs.
Explore Guide Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.